Infibeam Avenues Limited has informed the Exchange regarding Outcome of Board Meeting held on August 08, 2025 for Unaudited Financial Results, Increase in Authorized Share Capital, Transfer of Platform Business, Investment and Convening of 15th AGM..
CCAVENUE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.1 pts more than its Financial Technology (Fintech) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Infibeam Avenues reported Q1FY26 consolidated gross revenue of INR 12,802 million, up 72% year-on-year, with adjusted profit after tax of INR 855 million, up 70% YoY, and EBITDA margin of 47%. The board approved doubling the authorized share capital from Rs. 350 crore to Rs. 700 crore by creating 350 crore additional equity shares of Re 1 each, subject to shareholder approval. The board also approved a slump sale of its E-commerce Platform Business Undertaking to subsidiary Rediff.com India Limited for a total consideration of Rs. 800.39 crore (Rs. 400 crore cash + Rs. 400.39 crore via fresh equity shares in Rediff.com). The platform business contributed 4.83% of FY25 turnover and 18.58% of net worth. Separately, Infibeam will invest up to Rs. 88 crore further in Rediff.com using Rights Issue proceeds, raising its stake in Rediff.com to not exceeding 83%. The 15th AGM is scheduled for September 29, 2025 via video conferencing.
For shareholders, the slump sale of the platform segment to Rediff.com, where Infibeam will hold over 80%, means the platform business is being hived off into the listed subsidiary for sharper focus, while the parent sharpens its focus on the higher-growth CCAvenue payments and Phronetic.ai businesses. The authorized capital hike signals room for future fundraising or share issuance, which is mildly dilutive in tone. Strong Q1 results support near-term sentiment, but final outcome depends on shareholder and regulatory approvals for the slump sale.